Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  WebMD Health Corp.    WBMD

Delayed Quote. Delayed  - 02/12 03:59:59 pm
48.92 USD   -2.06%
02/04 WEBMD HEALTH : to Present at Upcoming Investor Conferences
02/02 WEBMD HEALTH : Announces Fourth Quarter Earnings Release Date and Co..
01/14DJWebMD Denies Takeover Talks, Stock Falls -- Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales470515580634690740
Operating income (EBITDA)28,284,3159192217243
Operating profit (EBIT)-0,1757,796,3128148169
Pre-Tax Profit (EBT)-25,228,8----
Net income-20,315,142,164,978,993,4
P/E ratio-35,912739,633,329,025,2
EPS ( $ )-0,400,311,001,471,691,94
Dividend per Share ( $ )------
Yield------
Reference price ( $ )14.3439.539.5548.9248.9248.92
Announcement Date02/21/2013
09:00pm
02/20/2014
09:00pm
02/24/2015
09:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt-12724517763,4-
Finance192----65,5
Operating income (EBITDA)28,284,3159192217243
Leverage
(Debt/EBITDA)
-1,51x1,55x0,92x0,29x-
Capital Expenditure35,2-23,246,829,130,5
Book Value Per Share (BVPS)10,4 $4,25 $----
Cash Flow per Share------
Announcement Date02/21/2013
09:00pm
02/20/2014
09:00pm
02/24/2015
09:00pm
---
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 1 834 M$ -
Entreprise Value (EV) 2 010 M$ 1 897 M$
Valuation 2015e 2016e
P/E ratio (Price / EPS) 33,3x 29,0x
Capitalization / Revenue 2,89x 2,66x
EV / Revenue 3,17x 2,75x
EV / EBITDA 10,5x 8,76x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 20,1% 21,4%
operating Leverage (Delta EBIT / Delta Sales) 3,52x 1,80x
Net Margin (Net Profit / Revenue) 10,2% 11,4%
ROA (Net Profit / Asset) 5,20% 6,70%
ROE (Net Profit / Equities) 56,1% 43,2%
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   7,38% 4,22%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 1,97x 1,71x
Financial Leverage (Net Debt / EBITDA) 0,92x 0,29x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend